| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), REVB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 422.8K | - | - | |
| Dir | 44.8K | - | - | |
| Dir | 44.8K | - | - | |
| Dir | 44.2K | - | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2023 | Tidmarsh George F55 | Director | Sell | 27,771 | $0.52 | $14,438.14 | -100% | -79.8% | -97.4% | |
| Oct 16, 2023 | Tidmarsh George F55 | Director | Sell | 1,845 | $0.65 | $1,199.43 | -6.2% | -37.0% | -96.1% | |
| Oct 16, 2023 | Tidmarsh George F55 | Director | Sell | 10,957 | $0.66 | $7,242.58 | -20.7% | -37.0% | -96.1% | |
| Sep 28, 2023 | Tidmarsh George F55 | Director | Sell | 1,429 | $0.69 | $986.01 | -3.3% | -27.2% | -95.6% | |
| Sep 18, 2023 | Tidmarsh George F55 | Director | Sell | 25,500 | $0.74 | $18,895.00 | -39.3% | -24.5% | -95.8% | |
| Apr 18, 2023 | Tidmarsh George F55 | Director | Buy | 51,500 | $1.16 | $59,740.00 | +385.8% | -25.7% | -93.5% | |
| Feb 25, 2022 | Tidmarsh George F55 | Director, 10% Owner | Buy | 20,000 | $1.60 | $32,000.00 | +4.5% | -61.6% | -95.6% | |
| Feb 9, 2022 | Tidmarsh George F55 | Director, 10% Owner | Buy | 31,000 | $2.55 | $79,139.00 | +7.4% | -70.0% | -96.8% | |
| Feb 7, 2022 | Tidmarsh George F55 | Director, 10% Owner | Buy | 50,000 | $2.56 | $128,036.07 | +3.4% | -71.4% | -92.8% | |
| Sep 23, 2021 | Glazer Capital, LLC69 | 10% Owner | Sell | 654,546 | $10.08 | $6,597,823.68 | -63.2% | +1.3% | -97.4% |